• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[New oral anticoagulants for prophylaxis of stroke : Results of an expert conference on practical use in geriatric patients].

作者信息

Bahrmann Philipp, Harms Fred, Schambeck Christian Martin, Wehling Martin, Flohr Jürgen

机构信息

Institut für Biomedizin des Alterns, Friedrich-Alexander-Universität Erlangen-Nürnberg, Kobergerstr. 60, 90419, Nürnberg, Deutschland.

European Health Care Foundation, Zug, Schweiz.

出版信息

Z Gerontol Geriatr. 2016 Jul;49(5):460-1. doi: 10.1007/s00391-016-1095-0.

DOI:10.1007/s00391-016-1095-0
PMID:27357589
Abstract
摘要

相似文献

1
[New oral anticoagulants for prophylaxis of stroke : Results of an expert conference on practical use in geriatric patients].用于预防中风的新型口服抗凝剂：老年患者实际应用专家会议结果
Z Gerontol Geriatr. 2016 Jul;49(5):460-1. doi: 10.1007/s00391-016-1095-0.
2
[New oral anticoagulants for prophylaxis of stroke. Results of an expert conference on practical use in geriatric patients].[用于预防中风的新型口服抗凝剂。老年患者实际应用专家会议结果]
Z Gerontol Geriatr. 2016 Apr;49(3):216-26. doi: 10.1007/s00391-016-1027-z. Epub 2016 Feb 10.
3
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.直接口服抗凝剂在心房颤动合并心脏瓣膜病变患者中的应用。
J Am Heart Assoc. 2016 Feb 18;5(2):e002776. doi: 10.1161/JAHA.115.002776.
4
The introduction of novel oral anticoagulants in 2009 has been rightly heralded as a major therapeutic breakthrough.2009年新型口服抗凝剂的引入被恰当地誉为一项重大的治疗突破。
Wien Klin Wochenschr. 2014 Nov;126(21-22):691. doi: 10.1007/s00508-014-0670-x.
5
Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.新型口服抗凝剂在预防心房颤动中的作用：欧洲心律协会调查结果。
Europace. 2013 Oct;15(10):1526-32. doi: 10.1093/europace/eut292.
6
Warfarin in non-valvular atrial fibrillation.华法林在非瓣膜性心房颤动中的应用。
S Afr Med J. 2013 Oct 11;103(12):901-4. doi: 10.7196/samj.7172.
7
[Treatment safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation].[非维生素K口服抗凝剂在房颤患者中的治疗安全性]
Herz. 2016 Feb;41(1):37-47. doi: 10.1007/s00059-015-4383-3.
8
MY APPROACH to arial fibrillation patients with a bleeding risk.我对有出血风险的房颤患者的治疗方法。
Trends Cardiovasc Med. 2016 Jul;26(5):477-8. doi: 10.1016/j.tcm.2015.10.006. Epub 2016 Feb 6.
9
Anticoagulation for atrial fibrillation: state of the art and recommendations for a quickly moving target.心房颤动的抗凝治疗：最新进展及针对快速变化目标的建议。
Can J Cardiol. 2013 Jul;29(7 Suppl):S1-3. doi: 10.1016/j.cjca.2013.05.001.
10
[Anticoagulation and new therapeutic options in atrial fibrillation].[心房颤动的抗凝治疗及新的治疗选择]
Dtsch Med Wochenschr. 2016 Oct;141(22):1618-1623. doi: 10.1055/s-0042-113075. Epub 2016 Nov 4.

引用本文的文献

1
[Thromboembolism prophylaxis in old age].[老年患者的血栓栓塞预防]
Z Gerontol Geriatr. 2018 Apr;51(3):349-363. doi: 10.1007/s00391-018-1384-x. Epub 2018 Apr 5.

本文引用的文献

1
Minimizing the Risk of Bleeding with NOACs in the Elderly.降低老年人使用非维生素K拮抗剂口服抗凝药时的出血风险
Drugs Aging. 2016 Jul;33(7):491-500. doi: 10.1007/s40266-016-0376-z.
2
[New oral anticoagulants for prophylaxis of stroke. Results of an expert conference on practical use in geriatric patients].[用于预防中风的新型口服抗凝剂。老年患者实际应用专家会议结果]
Z Gerontol Geriatr. 2016 Apr;49(3):216-26. doi: 10.1007/s00391-016-1027-z. Epub 2016 Feb 10.
3
Antithrombotic treatment in elderly patients with atrial fibrillation: a practical approach.
老年房颤患者的抗栓治疗：一种实用方法。
BMC Cardiovasc Disord. 2015 Nov 4;15:143. doi: 10.1186/s12872-015-0137-7.
4
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.老年患者的抗栓治疗：欧洲心脏病学会血栓形成工作组专家立场文件
Eur Heart J. 2015 Dec 7;36(46):3238-49. doi: 10.1093/eurheartj/ehv304. Epub 2015 Jul 9.
5
Injuries and outcomes associated with traumatic falls in the elderly population on oral anticoagulant therapy.老年人口接受口服抗凝治疗时创伤性跌倒相关的损伤及后果
Injury. 2015 Sep;46(9):1765-71. doi: 10.1016/j.injury.2015.06.013. Epub 2015 Jun 17.
6
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis.直接口服抗凝剂用于老年人心房颤动卒中预防及静脉血栓栓塞症二级预防的疗效与危害：系统评价与荟萃分析
Circulation. 2015 Jul 21;132(3):194-204. doi: 10.1161/CIRCULATIONAHA.114.013267. Epub 2015 May 20.
7
Optimal Stroke Prevention in the Geriatric Patient with Atrial Fibrillation: Position Paper of an Interdisciplinary Expert Panel.老年房颤患者的最佳卒中预防：跨学科专家小组立场文件
Drug Res (Stuttg). 2015 Oct;65(10):505-14. doi: 10.1055/s-0034-1389984. Epub 2014 Oct 6.
8
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).在每日口服一次利伐沙班、直接 Xa 因子抑制剂与维生素 K 拮抗剂预防心房颤动卒中及栓塞试验（ROCKET AF）中，与华法林相比，利伐沙班在老年非瓣膜性心房颤动患者中的疗效和安全性。
Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.
9
Edoxaban versus warfarin in patients with atrial fibrillation.依度沙班与华法林用于房颤患者。
N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
10
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.比较阿哌沙班与华法林在心房颤动患者肾功能方面的疗效：来自 ARISTOTLE 试验的见解。
Eur Heart J. 2012 Nov;33(22):2821-30. doi: 10.1093/eurheartj/ehs274. Epub 2012 Aug 29.